1. Home
  2. STHO vs STIM Comparison

STHO vs STIM Comparison

Compare STHO & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STHO

Star Holdings Shares of Beneficial Interest

N/A

Current Price

$8.05

Market Cap

104.6M

Sector

Real Estate

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$1.25

Market Cap

105.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STHO
STIM
Founded
2022
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.6M
105.5M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
STHO
STIM
Price
$8.05
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
29.9K
1.1M
Earning Date
05-20-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
24.73
N/A
EPS
N/A
N/A
Revenue
$110,143,000.00
$52,776,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$1.17
52 Week High
$9.24
$5.34

Technical Indicators

Market Signals
Indicator
STHO
STIM
Relative Strength Index (RSI) 40.42 41.50
Support Level $7.72 $1.22
Resistance Level $8.09 $1.46
Average True Range (ATR) 0.24 0.10
MACD -0.09 0.01
Stochastic Oscillator 9.09 30.98

Price Performance

Historical Comparison
STHO
STIM

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: